Peptide Initiative

Peptides · Peptide comparison

CJC-1295 with DAC vs GHRP-6 (Growth Hormone Releasing Peptide-6)

Long-acting growth hormone releaser that works around the clock to boost your body's natural GH production with just one or two injections per week.

A synthetic hexapeptide that signals your pituitary to release growth hormone through a unique pathway, with emerging evidence of heart-protective benefits.

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeCJC-1295 with DAC2–2 mgGHRP-6 (Growth Hormone Releasing Peptide-6)100–100 mcg
FrequencyCJC-1295 with DACTwice weeklyGHRP-6 (Growth Hormone Releasing Peptide-6)Multiple times daily
AdministrationCJC-1295 with DACSubcutaneous injectionGHRP-6 (Growth Hormone Releasing Peptide-6)Subcutaneous injection
Cycle lengthCJC-1295 with DAC8-12 weeksGHRP-6 (Growth Hormone Releasing Peptide-6)8-12 weeks
Onset speedCJC-1295 with DACModerate (1-2 weeks)GHRP-6 (Growth Hormone Releasing Peptide-6)Moderate (1-2 weeks)
Evidence levelCJC-1295 with DACModerate human trials (Phase 1-2)GHRP-6 (Growth Hormone Releasing Peptide-6)Limited human trials

Efficacy

Benefit ratings

GH Elevation

CJC-1295 with DAC92%
GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating

Convenience

CJC-1295 with DAC95%
GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating

Recovery Support

CJC-1295 with DAC88%
GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating

Muscle Recovery and Growth

CJC-1295 with DACNo recorded rating
GHRP-6 (Growth Hormone Releasing Peptide-6)85%

Cellular Health and Protection

CJC-1295 with DACNo recorded rating
GHRP-6 (Growth Hormone Releasing Peptide-6)72%

Appetite and Nutrient Intake

CJC-1295 with DACNo recorded rating
GHRP-6 (Growth Hormone Releasing Peptide-6)88%

Technical data

Compound specifications

CJC-1295 with DAC

Molecular formula
C165H269N47O46
Molecular weight
3647.28 g/mol
Half-life
6-8 days
Bioavailability
~100% (subcutaneous)
CAS number
863288-34-0

GHRP-6 (Growth Hormone Releasing Peptide-6)

Molecular formula
C46H56N12O6
Molecular weight
873.0 g/mol
Half-life
~2.5 hours
Bioavailability
<1% oral, high subcutaneous
CAS number
87616-84-0

Protocols

Dosing compared

CJC-1295 with DAC

Subcutaneous

  • 1 mg (1000 mcg)Once weekly · 2-4 weeksA starting dose used in practice. The DAC version is long-acting (about a 6-8 day half-life), so weekly dosing keeps growth hormone and IGF-1 raised. In the Phase 1 trial a single dose raised GH for 6+ days and IGF-1 for up to 11 days. [2]
  • 2 mg (2000 mcg)Once weekly (or split twice weekly) · 8-12 weeksThe common maintenance dose, roughly in line with the 30-60 mcg/kg weekly range studied in the Phase 1 trial. [1][2] In the ascending-dose trials, single injections raised mean GH 2- to 10-fold for six or more days and IGF-I 1.5- to 3-fold for 9-11 days; 30 and 60 µg/kg doses were the best tolerated [2].
  • 2 mg per doseTwice weekly · 8-12 weeksA higher total weekly amount split into two doses, used by experienced users; near the top of the 30-60 mcg/kg weekly range from the clinical study. [2]

GHRP-6 (Growth Hormone Releasing Peptide-6)

Subcutaneous

  • ~100 mcg per injection (approx. 1 mcg/kg)1-3 times daily, on an empty stomach · Open-ended in research practiceResearch-practice GH-secretagogue dosing; the ~100 mcg anchor reflects the validated 1 mcg/kg GH-saturating dose, though no isolated subcutaneous human dose-response trial exists [6].

Intravenous

  • 1 mcg/kg bolus (optionally followed by 1 mcg/kg/hr infusion)Single bolus for acute GH testing; infusion studies ran up to ~34 hours · Acute test or infusion studyTrial-established near-maximal GH-releasing intravenous dose in healthy men; pituitary responsiveness maintained over prolonged infusion [6]. Dose-response in men: mean peak GH of 7.6, 16.5, and 68.7 µg/L at 0.1, 0.3, and 1.0 µg/kg respectively [7].

Applications

Best suited for

CJC-1295 with DAC

Growth Hormone Optimization
CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.
Muscle Building and Recovery
By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.
Anti-Aging and Longevity
Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.
Body Composition Improvement
The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.
Convenient Weekly Dosing
Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.

GHRP-6 (Growth Hormone Releasing Peptide-6)

Athletes and Serious Trainers
If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow.
Those Exploring Novel Peptide Protocols
GHRP-6 offers a unique mechanism through the ghrelin receptor, [9] making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects [7].
Longevity and Metabolic Health Enthusiasts
Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation [1] makes it interesting for those interested in broader health optimization beyond just muscle growth.

Safety profile

Side effects

CJC-1295 with DAC

Common

  • Injection site reactions
  • Water retention
  • Flushing
  • Tingling sensation

Uncommon

  • Headaches
  • Fatigue or lethargy
  • Joint discomfort

Serious

  • Carpal tunnel symptoms
  • Blood glucose elevation

GHRP-6 (Growth Hormone Releasing Peptide-6)

Common

  • Increased Appetite
  • Mild Joint or Muscle Discomfort
  • Water Retention or Mild Swelling

Uncommon

  • Sleep Disturbances
  • Mild Dizziness or Lightheadedness

Serious

  • Allergic Reaction

Research status

Safety & evidence

CJC-1295 with DAC

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.

Contraindications

  • Active cancer or history of malignancy
  • Pregnancy or breastfeeding
  • Pituitary tumors or disorders
  • Diabetic retinopathy
  • Uncontrolled diabetes

GHRP-6 (Growth Hormone Releasing Peptide-6)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. [3] The good news is that animal safety studies show excellent tolerability at high doses, [2] and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions.

Contraindications

  • Known allergy or sensitivity to any component of the peptide
  • Active cancer or history of cancer without medical clearance
  • Severe cardiovascular disease or uncontrolled hypertension
  • Acute critical illness or sepsis

Decision guide

Which is right for you?

CJC-1295 with DAC

Choose CJC-1295 with DAC if…

  • Boosting natural growth hormone production
  • Building lean muscle mass
  • Improving body composition
  • Anti-aging and longevity

GHRP-6 (Growth Hormone Releasing Peptide-6)

Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if…

  • Building lean muscle mass and improving body composition
  • Recovery from intense training programs and athletic performance
  • Supporting overall metabolic health and longevity markers
  • Exploring novel GH-stimulation pathways for those who respond well to peptide protocols